Entera Bio Ltd. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.08 | $-0.07 | +12.5% | Beat |
Back to ENTX overview · ENTX holders · ENTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.